AMLX insider transactions
Amylyx Pharmaceuticals Inc. (AMLX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for AMLX
- Chief Financial Officer Frates James M was granted 95,990 shares, increasing direct ownership by 58% to 261,628 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina was granted 74,660 shares, increasing direct ownership by 56% to 209,090 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B was granted 248,865 shares, increasing direct ownership by 7% to 3,583,548 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. was granted 248,865 shares, increasing direct ownership by 7% to 3,583,481 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Medical Officer Bedrosian Camille L was granted 95,990 shares, increasing direct ownership by 57% to 265,285 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. sold $423,760 worth of shares (29,282 units at $14.47), decreasing direct ownership by 0.87% to 3,334,616 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B sold $424,120 worth of shares (29,282 units at $14.48), decreasing direct ownership by 0.87% to 3,334,683 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Financial Officer Frates James M sold $114,851 worth of shares (7,909 units at $14.52), decreasing direct ownership by 5% to 165,638 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Medical Officer Bedrosian Camille L sold $94,205 worth of shares (6,461 units at $14.58), decreasing direct ownership by 4% to 169,295 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina sold $99,378 worth of shares (6,844 units at $14.52), decreasing direct ownership by 5% to 134,430 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina sold $48,352 worth of shares (3,419 units at $14.14), decreasing direct ownership by 2% to 141,274 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B sold $227,593 worth of shares (15,500 units at $14.68), decreasing direct ownership by 0.46% to 3,363,965 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Financial Officer Frates James M sold $52,097 worth of shares (3,557 units at $14.65), decreasing direct ownership by 2% to 173,547 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina sold $50,516 worth of shares (3,448 units at $14.65), decreasing direct ownership by 2% to 144,693 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. sold $227,618 worth of shares (15,500 units at $14.69), decreasing direct ownership by 0.46% to 3,363,898 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B exercised 200,000 shares at a strike of $7.57 and sold $1,878,094 worth of shares (138,167 units at $13.59), increasing direct ownership by 2% to 3,379,465 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. sold $1,877,570 worth of shares (138,188 units at $13.59) and exercised 200,000 shares at a strike of $7.57, increasing direct ownership by 2% to 3,379,398 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Director Milne George M Jr gifted 17,780 shares, decreasing direct ownership by 2% to 812,881 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Financial Officer Frates James M sold $36,954 worth of shares (3,326 units at $11.11), decreasing direct ownership by 2% to 177,104 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. sold $85,589 worth of shares (7,715 units at $11.09), decreasing direct ownership by 0.23% to 3,317,586 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B sold $85,596 worth of shares (7,715 units at $11.09), decreasing direct ownership by 0.23% to 3,317,632 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Director Firestone Karen bought $100,845 worth of shares (8,100 units at $12.45), increasing direct ownership by 15% to 63,100 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Medical Officer Bedrosian Camille L sold $94,418 worth of shares (6,580 units at $14.35), decreasing direct ownership by 4% to 175,756 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina sold $128,669 worth of shares (8,828 units at $14.58), decreasing direct ownership by 6% to 148,141 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B sold $429,469 worth of shares (29,933 units at $14.35), decreasing direct ownership by 0.89% to 3,325,347 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. sold $430,952 worth of shares (29,975 units at $14.38), decreasing direct ownership by 0.89% to 3,325,301 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Financial Officer Frates James M sold $154,650 worth of shares (10,558 units at $14.65), decreasing direct ownership by 4% to 280,430 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Medical Officer Bedrosian Camille L sold $175,518 worth of shares (12,039 units at $14.58), decreasing direct ownership by 6% to 182,336 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina sold $246,148 worth of shares (30,000 units at $8.20), decreasing direct ownership by 16% to 156,969 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- SEC Form 4 filed by Director Fonteyne Paul R.4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- SEC Form 4 filed by Director Firestone Karen4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- SEC Form 4 filed by Director Quimi Daphne4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- SEC Form 4 filed by Director Milne George M Jr4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- SEC Form 4 filed by Director Zeiher Bernhardt G4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina gifted 1,000 shares, decreasing direct ownership by 0.53% to 186,969 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Financial Officer Frates James M sold $37,806 worth of shares (10,896 units at $3.47), decreasing direct ownership by 4% to 290,988 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Medical Officer Bedrosian Camille L sold $43,082 worth of shares (12,425 units at $3.47), decreasing direct ownership by 6% to 194,375 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina sold $31,954 worth of shares (9,192 units at $3.48), decreasing direct ownership by 5% to 187,969 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B sold $74,482 worth of shares (21,490 units at $3.47), decreasing direct ownership by 0.64% to 3,355,280 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. sold $74,454 worth of shares (21,490 units at $3.46), decreasing direct ownership by 0.64% to 3,355,276 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Director Zeiher Bernhardt G bought $37,005 worth of shares (10,000 units at $3.70) (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina was granted 63,851 shares, increasing direct ownership by 48% to 197,161 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Medical Officer Bedrosian Camille L was granted 68,420 shares, increasing direct ownership by 49% to 206,800 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. was granted 180,118 shares, increasing direct ownership by 6% to 3,376,766 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B was granted 180,118 shares, increasing direct ownership by 6% to 3,376,770 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Financial Officer Frates James M was granted 68,420 shares, increasing direct ownership by 29% to 301,884 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. sold $14,483 worth of shares (4,595 units at $3.15), decreasing direct ownership by 0.14% to 3,196,648 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B sold $14,549 worth of shares (4,595 units at $3.17), decreasing direct ownership by 0.14% to 3,196,652 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina sold $5,022 worth of shares (1,611 units at $3.12), decreasing direct ownership by 1% to 133,310 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina sold $13,145 worth of shares (4,169 units at $3.15), decreasing direct ownership by 3% to 134,921 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. exercised 36,310 shares at a strike of $1.57, increasing direct ownership by 1% to 3,201,243 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Legal Officer Mazzariello Gina sold $12,839 worth of shares (3,678 units at $3.49), decreasing direct ownership by 3% to 139,090 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B sold $41,108 worth of shares (11,851 units at $3.47), decreasing direct ownership by 0.37% to 3,201,247 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. sold $41,104 worth of shares (11,855 units at $3.47), decreasing direct ownership by 0.37% to 3,164,933 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Director Milne George M Jr gifted 27,910 shares, decreasing direct ownership by 3% to 830,661 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. sold $30,202 worth of shares (7,471 units at $4.04), decreasing direct ownership by 0.23% to 3,176,788 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Cohen Joshua B sold $30,232 worth of shares (7,471 units at $4.05), decreasing direct ownership by 0.23% to 3,213,098 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Chief Medical Officer Bedrosian Camille L sold $30,007 worth of shares (5,421 units at $5.54), decreasing direct ownership by 4% to 138,380 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. exercised 63,690 shares at a strike of $1.57, increasing direct ownership by 2% to 3,184,259 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
- Co-Chief Executive Officer Klee Justin B. sold $59,429 worth of shares (18,589 units at $3.20), decreasing direct ownership by 0.59% to 3,120,569 units (SEC Form 4)4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)